12.05.2025 • NewsClariantDowCompetition

Clariant Denies Dow Europe’s Competition Law Allegations in €767 Million Claim

Clariant firmly denies Dow Europe’s 2020 competition law allegations against four chemical companies.

Clariant building in Pratteln, Switzerland
Clariant rejects Dow Europe’s competition law allegations against chemical companies in €767 million legal dispute.
© Clariant

Clariant, a sustainability-focused specialty chemical company, today announced that on 9 May 2025, the company received a claim for damages against four companies, including Clariant, from Dow Europe with the court of Munich, Germany. The claim alleges damages totaling to around €767 million in relation to infringement of competition law on the ethylene purchasing market which was sanctioned by the European Commission in July 2020. Clariant firmly rejects the allegation and will adamantly defend its position in the proceedings. Dow Europe was not a supplier of ethylene to Clariant and Clariant has substantiated economic evidence that the conduct of the parties did not produce any effect on the market.

Company

Clariant



Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.